Advocacy intelligence hub — real-time data for patient organizations
AHS Cancer Control Alberta — PHASE2
University Medical Center Groningen
Assiut University — PHASE1, PHASE2
Alpha Fusion Inc. — PHASE1
West China Hospital — PHASE3
Ankara University — NA
Washington University School of Medicine — PHASE2
Georgetown University — NA
Georgetown University — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance3
Thyrogen
(Thyrotropin alfa)Orphan drugstandardGenzyme Corporation
Thyroid Stimulating Hormone [EPC]
12.1 Mechanism of Action Thyrotropin (TSH) is a pituitary hormone that stimulates the thyroid gland to produce thyroid hormone. Binding of thyrotropin...
CABOMETYX
(cabozantinib)Orphan drugstandardExelixis, Inc.
12.1 Mechanism of Action In vitro biochemical and/or cellular assays have shown that cabozantinib inhibits the tyrosine kinase activity of MET, VEGFR-...
LENVIMA
(lenvatinib)Orphan drugstandardEisai Inc.
Kinase Inhibitor [EPC]
12.1 Mechanism of Action Lenvatinib is a kinase inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors V...
Mark Zafereo, MD
M.D. Anderson Cancer Center
📍 HOUSTON, TX
Sophie LEBOULLEUX, MD
Gustave Roussy, Cancer Campus, Grand Paris
Zhijun Chen, PhD, EdM, RD
Jiangxi Provincial Cancer Hospital
📍 NEW YORK, NY
Jochen H Lorch, M.D
Northwestern University
📍 CHICAGO, IL
Sonal Gupta, MD PhD
AffyImmune Therapeutics, Inc.
Manisha Shah
Ohio State University